Breakthrough Properties Unveils One Helix
Breakthrough Properties, renowned for its expertise in life science real estate, has officially unveiled One Helix, a cutting-edge research facility that has been fully leased to AstraZeneca. This remarkable development, situated within the prestigious Amsterdam University Medical Center (Amsterdam UMC), represents a significant advance in both scientific research capabilities and sustainable building practices.
A Partnership of Innovation
The collaboration between Breakthrough Properties and AstraZeneca began back in August 2023 when the entire building was leased before construction even started. Designed by the innovative architecture firm UNStudio, One Helix spans five stories and has been created with an outstanding commitment to sustainability, boasting a BREEAM Outstanding certification.
"One Helix showcases the potential of synergizing world-class science with exceptional sustainable design," commented Tom Renn, Senior Vice President for Acquisitions and Development at Breakthrough Properties. This facility is not just a place for research; it symbolizes a commitment to fostering environments that encourage groundbreaking scientific advancements.
A Sustainable Focus in Research
Amsterdam has positioned itself as a premier hub for life sciences, attracting leading research and medical institutions and creating rich opportunities for biopharma companies. One Helix is pivotal to Amsterdam UMC's growth, enhancing the innovation landscape in the region.
The facility is designed with various energy-efficient technologies aimed at ensuring ultra-low energy consumption and operational emissions intensity. Notable features include:
- - Geothermal storage for heating and cooling
- - Highly efficient air treatment systems
- - A triple-glazed glass façade with integrated solar shading
- - Rooftop solar panels that provide additional energy
These elements contribute to a workspace that promotes health and productivity, aligning with Breakthrough's vision to enhance energy efficiency and minimize carbon footprints while still providing cutting-edge research environments.
Landscaping and Accessibility
In keeping with Amsterdam's emphasis on green space, One Helix will also feature landscaped terraces and green roofs that incorporate native plant species and biophilic materials. The development includes substantial infrastructure for electric vehicle charging and extensive bicycle storage, reflecting the city's preference for cycling as a primary mode of transportation. This integrated approach aligns with Breakthrough's commitment to sustainable urban commuting and lifestyle.
Strategic Partnerships
The success of One Helix can be attributed to the collaborative effort among various partners, including structural engineer Aronsohn, project management group Savills, and general contractor De Vries en Verburg. Together, these teams have pushed the limits of high-performance building design while ensuring that the development remains all-electric and exceptionally efficient.
Austin Gilliland, Director of Acquisitions and Asset Management at Breakthrough Properties, expressed gratitude for the diverse group of collaborators, highlighting the essential role played by UNStudio and others in realizing this ambitious project.
Future Developments
Breakthrough Properties continues to be a leader in the life science sector, with an impressive portfolio exceeding 6 million square feet of properties in various stages across the USA and Europe, all underpinned by the same commitment to sustainability. Upcoming projects, including Vitrum in Cambridge and Trinity in Oxford, are following a similar trajectory toward achieving BREEAM Outstanding certification.
Conclusion
Breakthrough Properties’ One Helix stands as a beacon of innovation and sustainability in medical research infrastructure. It signals not only a remarkable milestone for AstraZeneca but also a promise for the future of scientific exploration and environmental responsibility in urban settings.